Nabulsi Azmi has filed 14 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 79200 shares of Phathom Pharmaceuticals, Inc. ($PHAT) on February 27, 2025.
Activity breakdown: 1 open-market purchase and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Common Stock | 79200 | $0.00 | 1,101,868.9300 | 63,176,210 | 7.74% | 0.13% |
| Feb. 27, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 63,176,210 | 9999.99% | 0.09% |
| Jan. 21, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | S | Common Stock | 7886 | $6.59 | 1,022,668.9300 | 63,176,210 | 0.77% | 0.01% |
| Dec. 19, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | S | Common Stock | 1118 | $8.00 | 1,028,581.9300 | 64,627,847 | 0.11% | 0.00% |
| July 15, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | S | Common Stock | 10901 | $11.72 | 1,029,699.9300 | 51,289,092 | 1.05% | 0.02% |
| May 31, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Common Stoock | 7500 | $0.00 | 249,567.0000 | 51,289,092 | 3.10% | 0.01% |
| Jan. 18, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 51,289,092 | 9999.99% | 0.25% |
| Nov. 1, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Common Stock | 32500 | $0.00 | 1,031,345.9300 | 0 | 3.25% | 0.00% |
| July 14, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Common Stock | 110000 | $0.00 | 998,845.9300 | 0 | 12.38% | 0.00% |
| July 14, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | D | Stock Option | 70000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 14, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | D | Stock Option | 150000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 11, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | P | Common Stock | 10000 | $8.26 | 887,622.2200 | 0 | 1.14% | 0.00% |
| Jan. 19, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Common Stock | 45000 | $0.00 | 877,622.2200 | 0 | 5.40% | 0.00% |
| Jan. 19, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Nabulsi Azmi | Chief Operating Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |